Potential mechanisms of uremic muscle wasting and the protective role of the mitochondria-targeted antioxidant Mito-TEMPO
- 1 June 2020
- journal article
- research article
- Published by Springer Nature in International Urology and Nephrology
- Vol. 52 (8) , 1551-1561
Abstract
Background Muscle wasting is common in patients with chronic kidney disease (CKD). Many studies report that mitochondrial dysfunction and endoplasmic reticulum (ER) stress are involved in the development of muscle wasting. However, treatment approaches to protect against muscle wasting are limited. In this study, we investigated the benefits and potential mechanism of Mito-TEMPO, a mitochondria-targeted antioxidant on uremic-induced muscle wasting. Methods Mice were randomly divided into four groups as follows: control group, CKD group, CKD + Mito-TEMPO group, and Mito-TEMPO group. Renal injury was assessed by measurement of serum creatinine and BUN along with PAS and Masson’s staining. Bodyweight, gastrocnemius muscle mass, grip strength, and myofiber cross-sectional areas were investigated to evaluate muscle atrophy. Muscle protein synthesis and proteolysis were evaluated by Western blot and real-time PCR. Inflammatory cytokines including TNF-α, IL-6, IL-1β, and MCP-1 were measured by ELISA kits. Oxidative stress markers such as SOD2 activity and MDA level in gastrocnemius muscle tissue were measured by colorimetric assay. Mitochondrial dysfunction was evaluated by transmission electron microscopy and real-time PCR. ER stress was evaluated by Western blot. Results Impaired renal function was significantly restored by Mito-TEMPO treatment. Severe muscle atrophy was observed in muscle tissues of CKD mice along with increased inflammatory factors, oxidative stress markers, mitochondrial dysfunction, and ER stress. However, these effects were significantly attenuated with Mito-TEMPO treatment. Conclusions Mito-TEMPO improved muscle wasting in CKD mice possibly through alleviating mitochondrial dysfunction and endoplasmic reticulum stress, providing a potential new therapeutic approach for preventing muscle wasting in chronic kidney disease.Keywords
Funding Information
- “The Belt and Road international cooperation project (18410741500)
- Interdisciplinary Program of Shanghai Jiao Tong University (YG2017MS07)
- the distinguished Young Scholar of Ninth people’s hospital (jyyq09201701)
This publication has 37 references indexed in Scilit:
- Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice GuidelineAnnals of Internal Medicine, 2013
- Interactions between sarco-endoplasmic reticulum and mitochondria in cardiac and skeletal muscle – pivotal roles in Ca2+ and reactive oxygen species signalingJournal of Cell Science, 2013
- Molecular and cellular mechanisms of skeletal muscle atrophy: an updateJournal of Cachexia, Sarcopenia and Muscle, 2012
- Oxidative stress and disuse muscle atrophyCurrent Opinion in Clinical Nutrition and Metabolic Care, 2012
- The E3 Ubiquitin Ligase TRAF6 Intercedes in Starvation-Induced Skeletal Muscle Atrophy through Multiple MechanismsMolecular and Cellular Biology, 2012
- Cross talk between mitochondria and NADPH oxidasesFree Radical Biology and Medicine, 2011
- Review of muscle wasting associated with chronic kidney diseaseThe American Journal of Clinical Nutrition, 2010
- Mitochondrial dysfunction and molecular pathways of diseaseExperimental and Molecular Pathology, 2007
- Reactive Oxygen Species Mediate Caspase Activation and Apoptosis Induced by Lipoic Acid in Human Lung Epithelial Cancer Cells through Bcl-2 Down-RegulationThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Molecular mechanisms activating muscle protein degradation in chronic kidney disease and other catabolic conditionsEuropean Journal of Clinical Investigation, 2005